Medincell, a commercial-stage pharmaceutical technology company developing a portfolio of long-acting injectable products in various therapeutic areas, has raised €42.9m (US$44.9m) through a private placement share offering to institutional investors…
France: Medincell raises €42.9m through private placement
…
…






